ClearideBio Therapeutics

ClearideBio Therapeutics is a biopharmaceutical company dedicated to catalyzing cutting-edge antibody-drug conjugate (ADC) innovations into life-changing treatments for cancer patients worldwide. Through efficient development and agile partnerships, we aim to deliver more tumor-specific actions with reduced systemic toxicity to unlock durable benefits for patients.